Clinical Trial Update: Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dienogest versus desogestrel and goserelin for uterine leiomyoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyoma

Drugs mentioned

• Desogestrel (Desogestrel)
• Dienogest (dienogest)
• Goserelin (Goserelin)

Snippet

Sponsor: University of Sao Paulo | Conditions: Uterine Leiomyoma | Phase 4 | Status: TERMINATED